MenaQ7
Commercial- Indications
- Cardiovascular health
Company intelligence / Profile preview
Omicron Pharmaceuticals
Beirut, Beirut Governorate, Lebanonomicron-pharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Commercial
01
Overview
Omicron Pharmaceuticals is an active private pharmaceutical and healthcare company founded in Lebanon in 2009. It manufactures and markets a broad range of finished pharmaceutical formulations and food/nutritional supplements across cardiovascular, metabolic, reproductive health, hematology, respiratory care, pediatrics and other domains. The company operates primarily as a commercial-stage business with no disclosed pipeline of novel drugs or clinical trial assets. Its reach extends throughout the MENA region with alliances to European manufacturers.
- Therapeutic areas
- Men's HealthPulmonologyEndocrinologyHematologyCardiovascular
- Modalities
- Small molecules (finished formulations)Nutraceuticals/food supplements
- Industry
- Food & Nutrition
02
Drug pipeline
15 assets14 more assets in the full pipeline.
Request access →03
Partnerships
Alliances with high-quality manufacturers in Europe for supply chain/manufacturing purposes
Beyond the preview
Go deeper on Omicron Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Omicron Pharmaceuticals.